{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:09:03Z","timestamp":1793261343816,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1053\/j.ajkd.2020.03.026","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:34:28Z","timestamp":1595439268000},"page":"272-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"title":["Alport Syndrome: Achieving Early Diagnosis and Treatment"],"prefix":"10.1053","volume":"77","author":[{"given":"Clifford E.","family":"Kashtan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib1","first-page":"374","article-title":"Pathologic characteristics of hereditary nephritis","volume":"95","author":"Churg","year":"1973","journal-title":"Arch Pathol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib2","first-page":"473","article-title":"Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport\u2019s syndrome)","volume":"27","author":"Hinglais","year":"1972","journal-title":"Lab Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.026_bib3","first-page":"213","article-title":"Alport\u2019s syndrome: emphasizing electron microscopic studies of the glomerulus","volume":"69","author":"Spear","year":"1972","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.026_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI112658","article-title":"Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis","volume":"78","author":"Kashtan","year":"1986","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.026_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1172\/JCI113057","article-title":"Alport familial nephritis. Absence of 28 kilodalton non-collagenous monomers of type IV collagen in glomerular basement membrane","volume":"80","author":"Kleppel","year":"1987","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/302106","article-title":"Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome","volume":"63","author":"Boye","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.026_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1681\/ASN.V12197","article-title":"Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome","volume":"12","author":"Heidet","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.026_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1073\/pnas.87.4.1606","article-title":"Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome","volume":"87","author":"Hostikka","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4960","key":"10.1053\/j.ajkd.2020.03.026_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.2349482","article-title":"Identification of mutations in the COL4A5 collagen gene in Alport syndrome","volume":"248","author":"Barker","year":"1990","journal-title":"Science"},{"issue":"23","key":"10.1053\/j.ajkd.2020.03.026_bib10","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","article-title":"Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome","volume":"10","author":"Cosgrove","year":"1996","journal-title":"Genes Dev"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1083\/jcb.135.5.1403","article-title":"Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome","volume":"135","author":"Miner","year":"1996","journal-title":"J\u00a0Cell Biol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib12","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","article-title":"Mouse model of X-linked Alport syndrome","volume":"15","author":"Rheault","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.026_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"Gross","year":"2003","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.026_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00467-012-2138-4","article-title":"Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative","volume":"28","author":"Kashtan","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"21","key":"10.1053\/j.ajkd.2020.03.026_bib17","first-page":"2080","article-title":"Diagnostic utility of exome sequencing for kidney disease [letter]. Reply","volume":"380","author":"Groopman","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"8618","key":"10.1053\/j.ajkd.2020.03.026_bib18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(88)90753-2","article-title":"Genetics of classic Alport's syndrome","volume":"2","author":"Flinter","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.026_bib19","first-page":"249","article-title":"Mapping of Alport syndrome to the long arm of the X chromosome","volume":"42","author":"Atkin","year":"1988","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.026_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0888-7543(89)90339-X","article-title":"Localization of the gene for classic Alport syndrome","volume":"4","author":"Flinter","year":"1989","journal-title":"Genomics"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib21","first-page":"1157","article-title":"A\u00a0mutation causing Alport syndrome with tardive hearing loss is common in the western United States","volume":"58","author":"Barker","year":"1996","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2009070784","article-title":"Genotype-phenotype correlation in X-linked Alport syndrome","volume":"21","author":"Bekheirnia","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.026_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-Linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.026_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cge.12258","article-title":"Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases","volume":"86","author":"Fallerini","year":"2014","journal-title":"Clin Genet"},{"issue":"12","key":"10.1053\/j.ajkd.2020.03.026_bib25","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1681\/ASN.2013080912","article-title":"Improving mutation screening in familial hematuric nephropathies through next generation sequencing","volume":"25","author":"Moriniere","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2020.03.026_bib26","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2215\/CJN.01000116","article-title":"Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome","volume":"11","author":"Kamiyoshi","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib27","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1046\/j.1523-1755.2002.00379.x","article-title":"COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome","volume":"61","author":"Longo","year":"2002","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.026_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ki.1985.63","article-title":"Genetic heterogeneity of Alport syndrome","volume":"27","author":"Feingold","year":"1985","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib29","first-page":"940","article-title":"Genetic heterogeneity among kindreds with Alport syndrome","volume":"38","author":"Hasstedt","year":"1986","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1053\/j.ajkd.2020.03.026_bib30","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-Linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.026_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-011-1836-7","article-title":"Women and Alport syndrome","volume":"27","author":"Rheault","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2020.03.026_bib32","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.00580116","article-title":"Alport syndrome in women and girls","volume":"11","author":"Savige","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jamaophthalmol.2013.1452","article-title":"Temporal macular thinning associated with X-linked Alport syndrome","volume":"131","author":"Ahmed","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrneph.2009.65","article-title":"Opinion: ocular features aid the diagnosis of Alport syndrome","volume":"5","author":"Savige","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.026_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J\u00a0Med Genet"},{"issue":"9","key":"10.1053\/j.ajkd.2020.03.026_bib36","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00467-015-3067-9","article-title":"Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease","volume":"30","author":"Lennon","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.026_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12882-019-1258-5","article-title":"Non-collagen genes role in digenic Alport syndrome","volume":"20","author":"Daga","year":"2019","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.026_bib38","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s00467-011-2084-6","article-title":"Evidence that NPHS2-R22Q predisposes to proteinuria and renal failure in familial hematuria","volume":"27","author":"Voskarides","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.026_bib39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12882-018-0906-5","article-title":"COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or modifier effect","volume":"19","author":"Voskarides","year":"2018","journal-title":"BMC Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2020.03.026_bib40","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s00467-008-0934-7","article-title":"The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy","volume":"23","author":"Tonna","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib41","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ndt\/gfn681","article-title":"Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome","volume":"24","author":"Marcocci","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.026_bib43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2215\/CJN.01210308","article-title":"Screening for CKD in children: a global controversy","volume":"4","author":"Hogg","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.026_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/j.ajkd.2018.10.011","article-title":"Update on the native kidney biopsy: core curriculum 2019","volume":"73","author":"Luciano","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2020.03.026_bib45","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.026_bib46","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ki.1995.163","article-title":"Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution","volume":"47","author":"Gubler","year":"1995","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib47","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ki.2013.479","article-title":"Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV alpha5 chain","volume":"85","author":"Hashimura","year":"2014","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib48","first-page":"986","article-title":"Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody","volume":"144","author":"Yoshioka","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2020.03.026_bib49","series-title":"GeneReviews","article-title":"Alport syndrome","author":"Kashtan","year":"2001"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.026_bib50","first-page":"405","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Gen Med"},{"issue":"7","key":"10.1053\/j.ajkd.2020.03.026_bib51","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/ndt\/gfh219","article-title":"Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis","volume":"19","author":"Gross","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2020.03.026_bib52","doi-asserted-by":"crossref","first-page":"436046","DOI":"10.5402\/2012\/436046","article-title":"Safety and efficacy of the ACE-inhibitor ramipril in Alport syndrome: the double-blind, randomized, placebo-controlled, multicenter phase III EARLY PRO-TECT Alport trial in pediatric patients","volume":"2012","author":"Gross","year":"2012","journal-title":"ISRN Pediatr"},{"issue":"11","key":"10.1053\/j.ajkd.2020.03.026_bib53","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.tips.2019.07.012","article-title":"Alport syndrome therapeutics: ready for prime-time players","volume":"40","author":"Omachi","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1053\/j.ajkd.2020.03.026_bib54","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ndt\/gfz131","article-title":"New therapeutic options for Alport syndrome","volume":"34","author":"Torra","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib55","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1399-3046.2006.00528.x","article-title":"Renal transplantation in patients with Alport syndrome","volume":"10","author":"Kashtan","year":"2006","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.026_bib56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF00868709","article-title":"Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative STudy","volume":"9","author":"Kashtan","year":"1995","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2020.03.026_bib57","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2215\/CJN.02190312","article-title":"Outcomes of male patients with Alport syndrome undergoing renal replacement therapy","volume":"7","author":"Temme","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620307344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620307344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:29:47Z","timestamp":1759462187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620307344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0272638620307344"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.026","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alport Syndrome: Achieving Early Diagnosis and Treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}